Provided by Tiger Trade Technology Pte. Ltd.

Mira Pharma

0.8550
+0.084811.01%
Volume:117.89K
Turnover:97.76K
Market Cap:35.80M
PE:-0.62
High:0.9000
Open:0.7400
Low:0.7212
Close:0.7702
52wk High:2.45
52wk Low:0.6000
Shares:41.88M
Float Shares:34.94M
Volume Ratio:13.96
T/O Rate:0.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3802
EPS(LYR):-1.3505
ROE:-217.12%
ROA:-129.55%
PB:4.39
PE(LYR):-0.63

Loading ...

Company Profile

Company Name:
Mira Pharma
Exchange:
NASDAQ
Establishment Date:
2020
Employees:
- -
Office Location:
1200 Brickell Avenue,Suite 1950 #1183,Miami,Florida,United States
Zip Code:
33131
Fax:
- -
Introduction:
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.

Directors

Name
Position
Erez Aminov
Chairman of the Board and Chief Executive Officer and Director
Denil Nanji Shekhat
Director
Edward MacPherson
Director
Matthew Paul Del Giudice
Director
Matthew Pratt Whalen
Director

Shareholders

Name
Position
Erez Aminov
Chairman of the Board and Chief Executive Officer and Director
Andriy Mushak
Chief Financial Officer